Richard L. White
发表
High-dose interleukin-2: is it still indicated for melanoma and RCC in an era of targeted therapies?
A. Amin,
R. White,
Asim Amin,
2013,
Oncology.
A. Bosserhoff,
R. Buettner,
D. Dréau,
1999,
Oncology research.
High-dose interleukin-2: is it still indicated for melanoma and RCC in an era of targeted therapies?
Asim Amin,
Richard L White,
Richard L. White,
2013,
Oncology.